IP Verse

Novel Immune Checkpoint Inhibitors

Patent No. EP3802922 (titled "Novel Immune Checkpoint Inhibitors") was filed by Boehringer Ingelheim on Jun 10, 2019. The application was issued on Apr 26, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJan 26, 2024VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3802922

BOEHRINGER INGELHEIM
Application Number
EP19740098A
Filing Date
Jun 10, 2019
Status
Revoked
May 2, 2025
Publication Date
Apr 26, 2023
External Links
Slate, Register , Google Patents